img

Global COVID-19 In-Vitro Diagnostics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global COVID-19 In-Vitro Diagnostics Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal COVID-19 In-Vitro Diagnostics Market
The global COVID-19 In-Vitro Diagnostics market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for COVID-19 In-Vitro Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for COVID-19 In-Vitro Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for COVID-19 In-Vitro Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of COVID-19 In-Vitro Diagnostics include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. in 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for COVID-19 In-Vitro Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of COVID-19 In-Vitro Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for COVID-19 In-Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COVID-19 In-Vitro Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global COVID-19 In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for COVID-19 In-Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc.



By Company


Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay

Segment by Application


Home
Hospital
Clinical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of COVID-19 In-Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of COVID-19 In-Vitro Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COVID-19 In-Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Rapid Diagnostic Test (RDT)
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Neutralization Assay
1.3 Market by Application
1.3.1 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 In-Vitro Diagnostics Market Perspective (2018-2033)
2.2 Global COVID-19 In-Vitro Diagnostics Growth Trends by Region
2.2.1 COVID-19 In-Vitro Diagnostics Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 COVID-19 In-Vitro Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 COVID-19 In-Vitro Diagnostics Market Dynamics
2.3.1 COVID-19 In-Vitro Diagnostics Industry Trends
2.3.2 COVID-19 In-Vitro Diagnostics Market Drivers
2.3.3 COVID-19 In-Vitro Diagnostics Market Challenges
2.3.4 COVID-19 In-Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COVID-19 In-Vitro Diagnostics by Players
3.1.1 Global COVID-19 In-Vitro Diagnostics Revenue by Players (2018-2023)
3.1.2 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COVID-19 In-Vitro Diagnostics, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global COVID-19 In-Vitro Diagnostics Market Concentration Ratio
3.4.1 Global COVID-19 In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 In-Vitro Diagnostics Revenue in 2023
3.5 Global Key Players of COVID-19 In-Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of COVID-19 In-Vitro Diagnostics, Product and Application
3.7 Global Key Players of COVID-19 In-Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 In-Vitro Diagnostics Breakdown Data by Type
4.1 Global COVID-19 In-Vitro Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033)
5 COVID-19 In-Vitro Diagnostics Breakdown Data by Application
5.1 Global COVID-19 In-Vitro Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
6.2 North America COVID-19 In-Vitro Diagnostics Market Size by Type
6.2.1 North America COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
6.2.2 North America COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033)
6.2.3 North America COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
6.3 North America COVID-19 In-Vitro Diagnostics Market Size by Application
6.3.1 North America COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
6.3.2 North America COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033)
6.3.3 North America COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
6.4 North America COVID-19 In-Vitro Diagnostics Market Size by Country
6.4.1 North America COVID-19 In-Vitro Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023)
6.4.3 North America COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
7.2 Europe COVID-19 In-Vitro Diagnostics Market Size by Type
7.2.1 Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
7.3 Europe COVID-19 In-Vitro Diagnostics Market Size by Application
7.3.1 Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
7.4 Europe COVID-19 In-Vitro Diagnostics Market Size by Country
7.4.1 Europe COVID-19 In-Vitro Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
8.2 China COVID-19 In-Vitro Diagnostics Market Size by Type
8.2.1 China COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
8.2.2 China COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033)
8.2.3 China COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
8.3 China COVID-19 In-Vitro Diagnostics Market Size by Application
8.3.1 China COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
8.3.2 China COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033)
8.3.3 China COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
9.2 Asia COVID-19 In-Vitro Diagnostics Market Size by Type
9.2.1 Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
9.3 Asia COVID-19 In-Vitro Diagnostics Market Size by Application
9.3.1 Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
9.4 Asia COVID-19 In-Vitro Diagnostics Market Size by Region
9.4.1 Asia COVID-19 In-Vitro Diagnostics Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia COVID-19 In-Vitro Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia COVID-19 In-Vitro Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Details
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 In-Vitro Diagnostics Introduction
11.1.4 Cellex Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.1.5 Cellex Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 In-Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 In-Vitro Diagnostics Introduction
11.3.4 Roche Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.3.5 Roche Recent Developments
11.4 BioMedomics
11.4.1 BioMedomics Company Details
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Introduction
11.4.4 BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.4.5 BioMedomics Recent Developments
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD COVID-19 In-Vitro Diagnostics Introduction
11.5.4 BD Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.5.5 BD Recent Developments
11.6 Henry Schein
11.6.1 Henry Schein Company Details
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Introduction
11.6.4 Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.6.5 Henry Schein Recent Developments
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Details
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.7.5 Safecare Bio-Tech Recent Developments
11.8 Mayo Clinic Laboratories
11.8.1 Mayo Clinic Laboratories Company Details
11.8.2 Mayo Clinic Laboratories Business Overview
11.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Introduction
11.8.4 Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.8.5 Mayo Clinic Laboratories Recent Developments
11.9 Chembio Diagnostics
11.9.1 Chembio Diagnostics Company Details
11.9.2 Chembio Diagnostics Business Overview
11.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Introduction
11.9.4 Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.9.5 Chembio Diagnostics Recent Developments
11.10 Mount Sinai Laboratory
11.10.1 Mount Sinai Laboratory Company Details
11.10.2 Mount Sinai Laboratory Business Overview
11.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Introduction
11.10.4 Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.10.5 Mount Sinai Laboratory Recent Developments
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Details
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Developments
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Details
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.12.5 Zhejiang Orient Gene Biotech Recent Developments
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Details
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.13.5 Innovita Biological Technology Recent Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Developments
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Details
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.15.5 Guangdong Hecin-Scientific Recent Developments
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Details
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
11.17 ADVAITE
11.17.1 ADVAITE Company Details
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Introduction
11.17.4 ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023)
11.17.5 ADVAITE Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Rapid Diagnostic Test (RDT)
Table 3. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 4. Key Players of Neutralization Assay
Table 5. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 6. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global COVID-19 In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global COVID-19 In-Vitro Diagnostics Market Share by Region (2018-2023)
Table 9. Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global COVID-19 In-Vitro Diagnostics Market Share by Region (2024-2033)
Table 11. COVID-19 In-Vitro Diagnostics Market Trends
Table 12. COVID-19 In-Vitro Diagnostics Market Drivers
Table 13. COVID-19 In-Vitro Diagnostics Market Challenges
Table 14. COVID-19 In-Vitro Diagnostics Market Restraints
Table 15. Global COVID-19 In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global COVID-19 In-Vitro Diagnostics Revenue Share by Players (2018-2023)
Table 17. Global Top COVID-19 In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
Table 18. Global COVID-19 In-Vitro Diagnostics Industry Ranking 2021 VS 2023 VS 2023
Table 19. Global 5 Largest Players Market Share by COVID-19 In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of COVID-19 In-Vitro Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of COVID-19 In-Vitro Diagnostics, Product and Application
Table 22. Global Key Players of COVID-19 In-Vitro Diagnostics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global COVID-19 In-Vitro Diagnostics Revenue Share by Application (2018-2023)
Table 30. Global COVID-19 In-Vitro Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global COVID-19 In-Vitro Diagnostics Revenue Share by Application (2024-2033)
Table 32. North America COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America COVID-19 In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. North America COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe COVID-19 In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Europe COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 46. China COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 47. China COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 48. China COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 49. China COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia COVID-19 In-Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 55. Asia COVID-19 In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia COVID-19 In-Vitro Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 62. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Cellex Company Details
Table 65. Cellex Business Overview
Table 66. Cellex COVID-19 In-Vitro Diagnostics Product
Table 67. Cellex Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Cellex Recent Developments
Table 69. Abbott Company Details
Table 70. Abbott Business Overview
Table 71. Abbott COVID-19 In-Vitro Diagnostics Product
Table 72. Abbott Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Abbott Recent Developments
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche COVID-19 In-Vitro Diagnostics Product
Table 77. Roche Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Roche Recent Developments
Table 79. BioMedomics Company Details
Table 80. BioMedomics Business Overview
Table 81. BioMedomics COVID-19 In-Vitro Diagnostics Product
Table 82. BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 83. BioMedomics Recent Developments
Table 84. BD Company Details
Table 85. BD Business Overview
Table 86. BD COVID-19 In-Vitro Diagnostics Product
Table 87. BD Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 88. BD Recent Developments
Table 89. Henry Schein Company Details
Table 90. Henry Schein Business Overview
Table 91. Henry Schein COVID-19 In-Vitro Diagnostics Product
Table 92. Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Henry Schein Recent Developments
Table 94. Safecare Bio-Tech Company Details
Table 95. Safecare Bio-Tech Business Overview
Table 96. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product
Table 97. Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Safecare Bio-Tech Recent Developments
Table 99. Mayo Clinic Laboratories Company Details
Table 100. Mayo Clinic Laboratories Business Overview
Table 101. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product
Table 102. Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Mayo Clinic Laboratories Recent Developments
Table 104. Chembio Diagnostics Company Details
Table 105. Chembio Diagnostics Business Overview
Table 106. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 107. Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Chembio Diagnostics Recent Developments
Table 109. Mount Sinai Laboratory Company Details
Table 110. Mount Sinai Laboratory Business Overview
Table 111. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product
Table 112. Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 113. Mount Sinai Laboratory Recent Developments
Table 114. Ortho Clinical Diagnostics Company Details
Table 115. Ortho Clinical Diagnostics Business Overview
Table 116. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 117. Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Ortho Clinical Diagnostics Recent Developments
Table 119. Zhejiang Orient Gene Biotech Company Details
Table 120. Zhejiang Orient Gene Biotech Business Overview
Table 121. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product
Table 122. Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Zhejiang Orient Gene Biotech Recent Developments
Table 124. Innovita Biological Technology Company Details
Table 125. Innovita Biological Technology Business Overview
Table 126. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product
Table 127. Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Innovita Biological Technology Recent Developments
Table 129. Guangzhou Wondfo Biotech Company Details
Table 130. Guangzhou Wondfo Biotech Business Overview
Table 131. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product
Table 132. Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Guangzhou Wondfo Biotech Recent Developments
Table 134. Guangdong Hecin-Scientific Company Details
Table 135. Guangdong Hecin-Scientific Business Overview
Table 136. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product
Table 137. Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Guangdong Hecin-Scientific Recent Developments
Table 139. Dynamiker Biotechnology (Tianjin) Company Details
Table 140. Dynamiker Biotechnology (Tianjin) Business Overview
Table 141. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product
Table 142. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 143. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 144. ADVAITE Company Details
Table 145. ADVAITE Business Overview
Table 146. ADVAITE COVID-19 In-Vitro Diagnostics Product
Table 147. ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business (2018-2023) & (US$ Million)
Table 148. ADVAITE Recent Developments
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global COVID-19 In-Vitro Diagnostics Market Share by Type: 2023 VS 2033
Figure 3. Rapid Diagnostic Test (RDT) Features
Figure 4. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 5. Neutralization Assay Features
Figure 6. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 7. Global COVID-19 In-Vitro Diagnostics Market Share by Application: 2023 VS 2033
Figure 8. Home Case Studies
Figure 9. Hospital Case Studies
Figure 10. Clinical Case Studies
Figure 11. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 12. Global COVID-19 In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global COVID-19 In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global COVID-19 In-Vitro Diagnostics Market Share by Region: 2023 VS 2033
Figure 15. Global COVID-19 In-Vitro Diagnostics Market Share by Players in 2023
Figure 16. Global Top COVID-19 In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 In-Vitro Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 In-Vitro Diagnostics Revenue in 2023
Figure 18. North America COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 20. North America COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 21. North America COVID-19 In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 22. United States COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe COVID-19 In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 26. Europe COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 27. Europe COVID-19 In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 28. Germany COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China COVID-19 In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 36. China COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 37. Asia COVID-19 In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 39. Asia COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 40. Asia COVID-19 In-Vitro Diagnostics Market Share by Region (2018-2033)
Figure 41. Japan COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America COVID-19 In-Vitro Diagnostics Market Share by Country (2018-2033)
Figure 51. Brazil COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries COVID-19 In-Vitro Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Cellex Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 60. BioMedomics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 61. BD Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 62. Henry Schein Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 63. Safecare Bio-Tech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 64. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 65. Chembio Diagnostics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 66. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 67. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 68. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 69. Innovita Biological Technology Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 70. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 71. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 72. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 73. ADVAITE Revenue Growth Rate in COVID-19 In-Vitro Diagnostics Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries